Clinical Trials Directory

Trials / Conditions / Recurrent Uterine Sarcoma

Recurrent Uterine Sarcoma

15 registered clinical trials studyying Recurrent Uterine Sarcoma.

StatusTrialSponsorPhase
CompletedFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe
NCT01846520
City of Hope Medical CenterN/A
CompletedCarboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
NCT01652794
Case Comprehensive Cancer CenterPhase 1
CompletedStress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
NCT01764789
Ohio State University Comprehensive Cancer CenterN/A
CompletedTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
NCT01155258
University of Southern CaliforniaPhase 1
TerminatedTemsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus
NCT01061606
National Cancer Institute (NCI)Phase 2
CompletedTherapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
NCT01553539
Wake Forest University Health SciencesPhase 2
CompletedStereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignan
NCT01079832
Case Comprehensive Cancer CenterPhase 2
CompletedAZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT00659360
National Cancer Institute (NCI)Phase 2
CompletedSunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
NCT00378911
National Cancer Institute (NCI)Phase 2
CompletedZiv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissu
NCT00390234
National Cancer Institute (NCI)Phase 2
CompletedSorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
NCT00245102
National Cancer Institute (NCI)Phase 2
CompletedSorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer
NCT00238121
National Cancer Institute (NCI)Phase 2
TerminatedEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
NCT00087191
National Cancer Institute (NCI)N/A
CompletedImatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer
NCT00075400
National Cancer Institute (NCI)Phase 2
Completed17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymph
NCT00004241
National Cancer Institute (NCI)Phase 1